• About
  • What is VICH
  • Role of VICH
  • VICH Structure
  • VICH Process
  • What is the VICH Outreach Forum
• Guidelines
  • General
  • Biologicals
  • Pharmaceuticals
  • Pharmacovigilance
• Activities
  • Dates of next meetings
  • Dates of next Public conference
  • Public consultations
• Library
  • Press releases
  • VICH Statements
  • VICH Steering Committee Minutes
  • VICH Outreach Forum minutes
  • Concept Papers
  • Procedural Guidance
  • Organisational documents (Priorities, Strategy and charter)
  • Conference documents archive
  • Other Documents
• Training
  • General training material
  • Module 1 - General Topics
  • Module 2 - Quality
  • Module 3 - Efficacy
  • Module 4 - Safety
  • Module 5 - Biologicals
  • Module 6 - Pharmacovigilance
• Contact

Members login

Remember me next time

I agree to the privacy policy

• 
• 
• 

Guidelines

• Quality
  • Analytical validation
  • Impurities
  • Stability
  • Specifications
• Safety
  • Environmental safety
  • Metabolism and residue kinetics
  • Toxicology
  • Target animal safety
  • Antimicrobial safety
• Efficacy
  • Good clinical practice
  • Anthelmintics
  • Bioequivalence

Good clinical practice

• Good Clinical Practices
  VICH GL9 (GCP) June 2000 - Implemented in July 2001